These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1836935)

  • 21. [Measurement of retinal circulation times in non-proliferative diabetic retinopathy by use of fluorescein video angiography and image analysis system].
    Tsuchida Y
    Nippon Ganka Gakkai Zasshi; 1991 Jan; 95(1):73-8. PubMed ID: 2042532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Measurement of retinal blood flow velocity by scanning laser ophthalmoscopic fluorescein fundus angiography in experimental retinal vein obstruction].
    Katoh C
    Nippon Ganka Gakkai Zasshi; 1998 May; 102(5):307-11. PubMed ID: 9619022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.
    Bursell SE; Takagi C; Clermont AC; Takagi H; Mori F; Ishii H; King GL
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2711-20. PubMed ID: 9418723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of and tolerance to intracavernous injection of moxisylyte in patients with erectile dysfunction: effect/dose relationship versus placebo].
    Navratil H; Costa P; Louis JF; Andro MC; Saur P
    Prog Urol; 1995 Nov; 5(5):690-6. PubMed ID: 8580980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mean retinal circulation time as determined by fluorescein angiography in normal, prediabetic, and chemical-diabetic subjects.
    Soeldner JS; Christacopoulos PS; Gleason RE
    Diabetes; 1976; 25(2 SUPPL):903-8. PubMed ID: 971794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of moxisylyte in healthy volunteers after intravenous and oral administration.
    Costa P; Bressolle F; Bromet-Petit M; Mosser J; Sarrazin B
    J Pharm Sci; 1992 Dec; 81(12):1223-6. PubMed ID: 1491345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diameter of retinal vessels in patients with diabetic macular edema is not altered by intravitreal ranibizumab (lucentis).
    Terai N; Haustein M; Siegel A; Stodtmeister R; Pillunat LE; Sandner D
    Retina; 2014 Jul; 34(7):1466-72. PubMed ID: 24457978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats.
    Bursell SE; Clermont AC; Oren B; King GL
    Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):596-607. PubMed ID: 7890491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synchronous determination of retinal circulation times in both eyes.
    Laux U; Eckert G; Pauschinger P
    Ann Ophthalmol; 1979 May; 11(5):777-80. PubMed ID: 464509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of 14C-moxisylyte in hairless rat. Comparison between intravenous and oral route.
    Neau B; Roux J; Lambrey B; Courtiol C; Marty JP; Grislain L
    Arzneimittelforschung; 1995 Jan; 45(1):10-4. PubMed ID: 7893260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Retinal circulation time in diabetes (author's transl)].
    Caballero-Presencia A
    Rev Esp Otoneurooftalmol Neurocir; 1974; 32(186):79-82. PubMed ID: 4849644
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of systemic administration of valsartan, an angiotensin II type 1 receptor blocker, on retinal circulation in healthy humans.
    Nagaoka T; Takahashi A; Sato E; Yokota H; Izumi N; Yoshida A
    Eye (Lond); 2009 Jun; 23(6):1491-2. PubMed ID: 18776862
    [No Abstract]   [Full Text] [Related]  

  • 33. [The behavior of EOG after coffee-intake].
    Müller W; Haase E; Wedeking K; Niedlich R
    Klin Monbl Augenheilkd; 1973 Mar; 162(3):379-83. PubMed ID: 4713737
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of caffeine on the human macular circulation.
    Lotfi K; Grunwald JE
    Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3028-32. PubMed ID: 1938279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Retinal circulation and ocular blood barrier in diabetic retinopathy].
    Nakahashi K; Inoue M; Azumi A; Inoue M
    Nippon Ganka Gakkai Zasshi; 1992 May; 96(5):670-6. PubMed ID: 1621615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy.
    Bursell SE; Clermont AC; Kinsley BT; Simonson DC; Aiello LM; Wolpert HA
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):886-97. PubMed ID: 8603873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinal circulation after carotid artery revascularization.
    Cardia G; Porfido D; Guerriero S; Loizzi D; Giancipoli G
    Angiology; 2011 Jul; 62(5):372-5. PubMed ID: 21596695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of moxisylyte in healthy volunteers after intracavernous injection of increasing doses.
    Bressolle F; Costa P; Rouzier-Panis R; Marquer C
    Eur J Clin Pharmacol; 1996; 49(5):411-5. PubMed ID: 8866639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of treatment on retinal circulation, platelet aggregation and blood viscosity in insulin-dependent and noninsulin-dependent diabetics.
    Uchimura I
    Bull Tokyo Med Dent Univ; 1983 Mar; 30(1):17-24. PubMed ID: 6339093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Retinal blood circulation times in patients with type II diabetes mellitus].
    Bertram B; Wolf S; Elbers M; Jussen W; Jung F; Reim M
    Fortschr Ophthalmol; 1988; 85(4):413-5. PubMed ID: 3220366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.